Press Release – Leapfrog Hospital Safety Grades, Spring 2021
The Leapfrog Group, a national nonprofit representing hundreds of the nation’s most influential employers and purchasers of health care, driven in Florida by the Florida Alliance for Healthcare Value, has announced the spring 2021 Leapfrog Hospital Safety Grades.
Leapfrog Group Annual Report on Maternity Care
The Leapfrog Group, a national watchdog organization of employers and other purchasers focused on health care safety and quality, today released its 2021 Maternity Care Report, which measures hospital performance against best practices across three high-risk areas of maternity care: cesarean sections, episiotomies, and early elective deliveries. The report is based on results of the 2020 Leapfrog Hospital Survey, the flagship initiative of The Leapfrog Group. It is the only source of data on these measures that is publicly reported nationally, by hospital.
Winter 2021 E-newsletter
In our Winter 2021 newsletter, you will find a link to an important video providing facts on the COVID-19 vaccines, produced as a collaboration between the National Alliance of Healthcare Purchaser Coalitions and the Centers for Disease Control. We’ve shared Information on our 2-part virtual Annual Conference/Annual Meeting of the Board of Directors coming in […]
Press Release – Leapfrog Hospital Safety Grades, Fall 2020
The Leapfrog Group, a national nonprofit representing hundreds of the nation’s most influential employers and purchasers of health care, driven in Florida by the Florida Alliance for Healthcare Value, has announced the fall 2020 Leapfrog Hospital Safety Grades.
Press Release – Leapfrog Top Hospitals 2020
The Leapfrog Group, an independent national watchdog organization of employers and other purchasers focused on health care safety and quality, has announced two prestigious awards: the annual Top Hospital Award, the Nation’s most elite recognition for hospital excellence, and a new national award honoring pandemic heroes.
Biosimilar Drug Trends for 2020
The Florida Alliance for Healthcare Value hosted a webinar on September 22, 2020, in partnership with its affiliate member Amgen. Chad Pettit, Amgen’s Executive Director of Marketing and Global Biosimilars Commercial Lead, shared highlights of the company’s 2020 Biosimilar Trends Report.
Fall 2020 E-newsletter
This edition of the newsletter is packed with information on our current programs and upcoming events, spanning a variety of timely topics such as the growing opioid and mental health crisis, alternative approaches to substance use disorder treatment, value-based insurance design strategies and trends and policy changes in the drug value chain. Read entire newsletter
Summer Education Series Explored Some of the Biggest Healthcare Challenges Facing Employers
Despite the pandemic, the Florida Alliance continues to feature highly accomplished speakers who are leaders in their field. Each session in the Summer Education Series featured nationally renowned experts who shared best practices and case studies on session topics and commented on related Florida Alliance initiatives. A key element of the presentations and discussion was what role providers, employers/purchasers, health plans, manufacturers, PBMs and patients need to play to move efforts toward affordable, quality heath care forward.
Migraine Headache and the
COVID-19 Pandemic
Approximately 13 percent of Americans experience migraine headaches, a recurring type of headache that causes severe, throbbing or pulsing pain and can be accompanied by nausea and sensitivity to light and sound. In the working population, migraine headache is the fifth most disabling medical condition in the United States.
Economic Costs of the Opioid Crisis for Employers
A considerable portion of the nearly $631 billion dollars in economic costs (estimated total US costs from 2015-2018) of the opioid crisis is borne by employers, including increased spending on health care and lost productivity. To better manage their financial risks and improve the health of their employees, employers should consider strategies that encompass both preventative and supportive measures to help those experiencing opioid use disorder (OUD) better manage their conditions and move toward recovery.
